Also, in lung cancer cells, proliferating cell nuclear antigen (PCNA) expression and extracellular signal-regulated kinases 1/2 (ERK1/2) activation were induced upon THs treatment13, suggesting the possible role of THs and their receptors in lung cancer progression. Here, MAPK3 is linked to lung carcinoma.